1-3 of 3
Shom Goel
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase II Study of Abemaciclib for Patients with Retinoblastoma-Positive, Metastatic Triple-Negative Breast Cancer

Shom Goel, Bojana Jovanović, Xiangying Chu, Melissa Hughes, Timothy K. Erick, Douglas Russo, Molly DiLullo, Eileen Wrabel, Rinath Jeselsohn, Nancy U. Lin, Nabihah Tayob, Elizabeth Mittendorf, Stuart Schnitt, Sara M. Tolaney
Journal: Clinical Cancer Research
Clin Cancer Res (2025) 31 (8): 1427–1436.
https://doi.org/10.1158/1078-0432.CCR-24-2647
Published: 14 April 2025
View articletitled, A Phase II Study of Abemaciclib for Patients with Retinoblastoma-Positive, Metastatic Triple-Negative Breast Cancer
Open the PDF for A Phase II Study of Abemaciclib for Patients with Retinoblastoma-Positive, Metastatic Triple-Negative Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Integrative Multiomic Profiling of Triple-Negative Breast Cancer for Identifying Suitable Therapies

Bojana Jovanović, Sarah E. Church, Kara M. Gorman, Khrystyna North, Edward T. Richardson, III, Molly DiLullo, Victoria Attaya, Julie Kasparian, Ayesha Mohammed-Abreu, Gregory Kirkner, Melissa E. Hughes, Nancy U. Lin, Elizabeth A. Mittendorf, Stuart J. Schnitt, Sara M. Tolaney, Shom Goel
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (20): 4768–4779.
https://doi.org/10.1158/1078-0432.CCR-23-1242
Published: 15 October 2024
View articletitled, Integrative Multiomic Profiling of Triple-Negative Breast Cancer for Identifying Suitable Therapies
Open the PDF for Integrative Multiomic Profiling of Triple-Negative Breast Cancer for Identifying Suitable Therapies in another window
Includes: Supplementary data
Journal Articles

Overall Survival and Exploratory Biomarker Analyses of Abemaciclib plus Trastuzumab with or without Fulvestrant versus Trastuzumab plus Chemotherapy in HR+, HER2+ Metastatic Breast Cancer Patients

Sara M. Tolaney, Shom Goel, Jorge Nadal, Hannelore Denys, Manuel R. Borrego, Lacey M. Litchfield, Jiangang Liu, Adams K. Appiah, Yanyun Chen, Fabrice André
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (1): 39–49.
https://doi.org/10.1158/1078-0432.CCR-23-1209
Published: 05 January 2024
View articletitled, Overall Survival and Exploratory Biomarker Analyses of Abemaciclib plus Trastuzumab with or without Fulvestrant versus Trastuzumab plus Chemotherapy in HR+, HER2+ Metastatic Breast Cancer Patients
Open the PDF for Overall Survival and Exploratory Biomarker Analyses of Abemaciclib plus Trastuzumab with or without Fulvestrant versus Trastuzumab plus Chemotherapy in HR+, HER2+ Metastatic Breast Cancer Patients in another window
Includes: Supplementary data